NCT03678961 is a clinical trial of external rotation of leg in Sciatic Nerve Block, sponsored by Asan Medical Center.

Who is sponsoring NCT03678961?

NCT03678961 is sponsored by Asan Medical Center.

What drugs are being tested in NCT03678961?

Interventions in NCT03678961: external rotation of leg, hip flexion and knee flexion.

What condition does NCT03678961 study?

NCT03678961 studies Sciatic Nerve Block.

Is NCT03678961 still recruiting?

NCT03678961 is currently completed. Last updated 20 December 2018.

Last reviewed 2018-12-20 · How we verify

NCT03678961

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Leg Position on the Sciatic Nerve on Sonogram

Completed Last updated 20 December 2018

What this trial tests

trial testing external rotation of leg in Sciatic Nerve Block in 45 participants. Completed in 11 October 2018.

Timeline

30 August 2018

Primary endpoint
11 October 2018

11 October 2018

Quick facts

Lead sponsor	Asan Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	45
Start date	30 August 2018
Primary completion	11 October 2018
Estimated completion	11 October 2018
Sites	1 location across South Korea

Drugs / interventions tested

external rotation of leg
hip flexion and knee flexion

Conditions studied

Sciatic Nerve Block — all drugs for Sciatic Nerve Block →

Sponsor

Asan Medical Center

Who can join

Adults 18 to 80, any sex, with Sciatic Nerve Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Little is known about which posture of lower extremity makes it easier to access to the sciatic nerve. In this study, the investigators aimed to identify the most appropriate positioning of the lower extremity during anterior-approach ultrasound-guided sciatic nerve block.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Asan Medical Center trials

Trials by the same sponsor.

NCT07530393 — Blood Viscosity and Outcomes After Elective Craniotomy · not yet recruiting
NCT07010497 — A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Be · Phase 2 · recruiting
NCT07382505 — Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cerv · not yet recruiting
NCT07489092 — Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge · NA · recruiting
NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03678961 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asan Medical Center
Last refreshed: 20 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03678961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing